Literature DB >> 2350475

Effect of age on response of secondary hypertension to specific treatment.

D H Streeten1, G H Anderson, S Wagner.   

Abstract

There is substantial evidence to show that correction of the causes of secondary forms of hypertension usually but certainly not always restores blood pressure to normal. We have analyzed the effect of age on the response of the blood pressure to the removal of the cause of hypertension in groups of patients with primary aldosteronism, renovascular hypertension, Cushing's syndrome and hypothyroid hypertension. In the patients studied, surgical or medical elimination of the mechanism responsible for the hypertension when the patients were below the age of 40 reduced diastolic blood pressure 1 to 2 years later to below 90 mm Hg in 24 of 25 patients. In the patients who were treated when they were over 40 years of age, blood pressure remained above 90 mm Hg after corrective treatment in 23 of 61 individuals (38%). In the 4 groups studied there was a significant correlation between age and post-treatment systolic and/or diastolic blood pressure. The findings indicate the importance of correcting secondary hypertension at an early age.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2350475     DOI: 10.1093/ajh/3.5.360

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  10 in total

Review 1.  Diagnosis and treatment of primary aldosteronism.

Authors:  Paolo Mulatero; Silvia Monticone; Franco Veglio
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

Review 2.  Atherosclerotic renal artery stenosis: surgery, percutaneous transluminal angioplasty, or medical therapy?

Authors:  P F Plouin; B Guéry; A La Batide Alanore
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

3.  Five-Year Outcomes of Gastric Bypass in Adolescents as Compared with Adults.

Authors:  Thomas H Inge; Anita P Courcoulas; Todd M Jenkins; Marc P Michalsky; Mary L Brandt; Stavra A Xanthakos; John B Dixon; Carroll M Harmon; Mike K Chen; Changchun Xie; Mary E Evans; Michael A Helmrath
Journal:  N Engl J Med       Date:  2019-05-16       Impact factor: 91.245

Review 4.  Primary aldosteronism. Results of surgical treatment.

Authors:  C Y Lo; P C Tam; A W Kung; K S Lam; J Wong
Journal:  Ann Surg       Date:  1996-08       Impact factor: 12.969

Review 5.  Secondary hypertension. An overview of its causes and management.

Authors:  D H Streeten; G H Anderson
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

6.  Five-year kidney outcomes of bariatric surgery differ in severely obese adolescents and adults with and without type 2 diabetes.

Authors:  Petter Bjornstad; Edward Nehus; Todd Jenkins; Mark Mitsnefes; Marva Moxey-Mims; John B Dixon; Thomas H Inge
Journal:  Kidney Int       Date:  2020-02-03       Impact factor: 10.612

Review 7.  The Relationship Between Psychosocial Status and Hypertensive Condition.

Authors:  Ștefania Matei; Stephen J Cutler; Marian Preda; Maria Dorobanțu; Corina Ilinca; Oana Gheorghe-Fronea; Luminița Rădulescu; Nicoleta Oprescu; Alexandru Deaconu; Corina Zorilă; Bogdan Dorobanțu
Journal:  Curr Hypertens Rep       Date:  2018-10-25       Impact factor: 5.369

Review 8.  Primary aldosteronism: A Japanese perspective.

Authors:  Fumitoshi Satoh; Ryo Morimoto; Yoshitsugu Iwakura; Yoshikiyo Ono; Masataka Kudo; Kei Takase; Sadayoshi Ito
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

9.  Clinical efficacy of percutaneous renal revascularization with stent placement in hypertension among patients with atherosclerotic renovascular diseases.

Authors:  Seyed Mohammad Hassan Adel; Seyed Masood Syeidian; Mohammad Najafi; Mohammad Nourizadeh
Journal:  J Cardiovasc Dis Res       Date:  2011-01

10.  Highlighting Indication of extracorporeal membrane oxygenation in endocrine emergencies.

Authors:  Anne Chao; Chih-Hsien Wang; Hao-Chun You; Nai-Kwoun Chou; Hsi-Yu Yu; Nai-Hsin Chi; Shu-Chien Huang; I-Hui Wu; Li-Jung Tseng; Ming-Hsien Lin; Yih-Sharng Chen
Journal:  Sci Rep       Date:  2015-08-24       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.